Prestige News

Total 82
Number Thumbnail Title Author Date Votes Views
82 Prestige Biopharma and Syntekabio Join Forces on AI-Driven Drug Development
김** | 2026.11.10 | Votes 0 | Views 277
김** 2026.11.10 0 277
81 Prestige Biopharma Unveils Subcutaneous Injection Platform at AAPS in the U.S., Explores Licensing Opportunities
김** | 2026.10.26 | Votes 0 | Views 749
김** 2026.10.26 0 749
80 Prestige Biopharma to Present Phase 1 Clinical Data for Pancreatic Cancer Drug Candidate PBP1510 at ESMO 2026
김** | 2026.10.23 | Votes 0 | Views 976
김** 2026.10.23 0 976
79 Prestige Biopharma Participates in CPHI Milan 2026 to Expand Global Partnerships
김** | 2026.10.07 | Votes 0 | Views 1190
김** 2026.10.07 0 1190
78 Prestige Biopharma IDC's Taeheung Kang, Director of Drug Development Division: 'Additional Pipelines Ready… Accelerating Resear
김** | 2026.10.01 | Votes 0 | Views 1258
김** 2026.10.01 0 1258
77 Prestige Biopharma Appoints Neil O’Connor as Board Director, Strengthening Expertise in CMC and Quality Management
김** | 2026.09.30 | Votes 0 | Views 1156
김** 2026.09.30 0 1156
76 Prestige Biopharma Receives Brazilian Marketing Authorization for Herceptin Biosimilar Tuznue
김** | 2026.09.28 | Votes 0 | Views 1584
김** 2026.09.28 0 1584
75 Prestige Biopharma’s Tuznue Receives Marketing Authorization in Trinidad and Tobago
김** | 2026.09.18 | Votes 0 | Views 1537
김** 2026.09.18 0 1537
74 Prestige Biopharma IDC Obtains ISO 14001 and ISO 45001 Certifications
김** | 2026.09.17 | Votes 0 | Views 1259
김** 2026.09.17 0 1259
73 Prestige Biopharma Successfully Concludes ‘Prestige Symposium’ on Aging
김** | 2026.09.09 | Votes 0 | Views 1788
김** 2026.09.09 0 1788